Memphis Pharmaceuticals

مادة اعلانية

Latest Update: 21 Nov 2024 16:25 Abu Dhabi Time.

Market Status: Closed

MPCI

Memphis Pharmaceuticals

57.61

EGP

0.010

0.02%

Open

57.60

Prev Close

57.60

PX_VOLUME

28,700

MARKET CAP (M)

DAY RANGE

57.40 - 58.70

52 WEEKS

19.66 - 69.50

Stock Statistics

Yearly Change

193.60%

Listed Shares (Million)

22.75

Earnings Multiple

3.18

Average 30-day trading volume

Price-to-book ratio

3.38

Earnings Per Share

11.29

Previous Dividend Distribution

Dividend Yield

0.00%

Financial Summary

Quarterly
Annual

Income Statements

	Period Ending:	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023
Total Revenue		207.33	234.79	247.14	182.65	223.37
Gross Profit		70.43	75.84	100.90	53.12	74.26
Operating Income		51.45	45.44	64.59	26.64	59.97
Profit Margin		12.10	35.56	23.52	13.56	24.79

	Period Ending:	Jun 30, 2024	Jun 30, 2023
Total Revenue	871.91	663.83
Gross Profit	300.29	212.95
Operating Income	188.12	98.85
Profit Margin	21.96	13.62

Balance Sheet

	Period Ending:	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023
Total Assets		1,217.04	1,127.34	1,004.16	795.79	785.66
Total Liabilities		1,067.96	1,059.62	856.04	667.63	680.70
Total Equity		149.08	67.73	148.12	128.16	104.95

	Period Ending:	Jun 30, 2024	Jun 30, 2023
Total Assets	1,217.04	785.66
Total Liabilities	1,067.96	680.70
Total Equity	149.08	104.95

Cash Flows Statements - Coming Soon

* In Million of Egypt Pound

Reminder: The financial information on this website is delayed information that are originates from certified data providers in the financial markets, who retain the rights and intellectual property of this data, absolving ADMN of any responsibility.

MPCI

Memphis Pharmaceuticals